Relative Bioavailability of an Extemporaneous Ondansetron 4-mg Capsule Formulation versus Solution

Y. W.Francis Lam, Martin A. Javors, Nassima Ait-Daoud, John D. Roache, Bankole A. Johnson

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Relative Bioavailability of an Extemporaneous Ondansetron 4-mg Capsule Formulation versus Solution'. Together they form a unique fingerprint.

Medicine & Life Sciences